Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Cidara Therapeutics Inc CDTX

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:CDTX)

Halper Sadeh LLC Encourages GIFI, MOVE, RMBI, CDTX Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire 6 days ago

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN

PR Newswire 6 days ago

HAPPY THANKSGIVING AND EQUITY ALERT: The M&A Class Action Firm Launches Investigation for the Merger - EXAS, SEE, CDTX, and MRSN

ACCESS Newswire 7 days ago

Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire 7 days ago

HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN

GlobeNewswire 7 days ago

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

GlobeNewswire 10 days ago

Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire 12 days ago

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-NUVSF, NDTAF, THS, and CDTX

PR Newswire 13 days ago

Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire November 17, 2025

Bullboard Posts (NDAQ:CDTX)

Buy buddy buy because it's taking off this morning.

Bought this stock cheaply in the pre market action and it's looking really good here today
coolfooldumbguy - June 23, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX): Developing Novel Dr

http://beyondspx.com/2024/08/02/cidara-therapeutics-inc-nasdaqcdtx-developing-novel-drug-fc-conjugate-immunotherapies/
MikeTester - August 3, 2024

missed this one

another one on my watchlist from last year,but doing  too many other things this month,so glta.
coolfooldumbguy - January 27, 2020

watching this one for

an entry point,so glta.
coolfooldumbguy - September 6, 2019